Why does prolonged exposure to synthetic progestins increase osteoporosis risk in postmenopausal women?

💡 Explanation

Synthetic progestins can suppress the hypothalamic-pituitary-ovarian axis, leading to decreased estrogen production; because bone health depends on estrogen's maintenance of bone density, its reduction accelerates bone resorption. Therefore, osteoporosis risk increases, rather than direct receptor interactions or calcium blockage being the primary driver.

• Why does severe dehydration rapidly induce intense thirst, despite the body's attempt at fluid conservation through increased ADH and water reabsorption in the kidneys' collecting ducts?
• If GLP-1 secretion is consistently inhibited, which consequence follows regarding insulin and glucagon regulation?
• A patient develops severe B12 deficiency due to autoimmune destruction of parietal cells in the stomach, leading to intrinsic factor absence. Which outcome affecting erythropoiesis becomes most likely?
• Which systemic shift results with chronically elevated insulin?
• Which failure mode becomes likely when a patient with a mutation affecting intestinal biotinidase experiences a biotin deficiency?
• Why does a dialysis patient experience increased bone fragility compared to a healthy individual?